Cindy Murray, NP

Shannon Nixon, MN NP

CMH-NP Conference Co-Chair
Nurse Practitioner, Malignant Hematology

Shannon Nixon is a Nurse Practitioner with the Malignant Hematology Program at the Princess Margaret Cancer Centre in Toronto, Ontario. She has over 20 years of experience caring for patients with acute leukemia and complex lymphomas. She is currently working on her Doctor of Nursing degree at the University of Toronto. Her thesis is focused on evaluating the implementation of shared-care programs in complex malignant hematology, to improve health equity and support patients with safe and effective care closer to home.

Dior Caruso MN-NP Adult, CHPCN(C)

Nurse Practitioner
Complex Malignant Hematology – Myeloma Program
Princess Margaret Cancer Centre
Toronto, ON

Dior Caruso is a Nurse Practitioner in the Multiple Myeloma Program at the Princess Margaret Cancer Centre. She completed the Master of Nursing Nurse Practitioner program at the University of Toronto and has over 10 years of experience working as an oncology nurse. Her current role focuses on providing care in an outpatient clinic to patients with multiple myeloma and other plasma cell disorders within the complex malignant hematology setting. She also holds a certification in palliative care and has a special interest in health advocacy.

Kayla Madsen, MN, NP-C, CON(C)

Specialty Nurse Practitioner
Cell Therapy & Transplant Program
Adjunct Lecturer
University of Toronto, Bloomberg Faculty of Nursing
Toronto, ON

Kayla Madsen is an experienced Nurse Practitioner with 15 years of specialized expertise in hematology and allogeneic stem cell transplantation. Over the course of her career, Kayla has worked in both inpatient and outpatient settings across Canada, contributing her skills to prominent healthcare institutions such as Princess Margaret Cancer Centre in Toronto and QEII Health Sciences Centre in Halifax. She has been published in leading academic journals for her research on post-transplant complications and management, aiming to improve patient outcomes. In her current role, she is responsible for the acute and long-term management of allogeneic and autologous transplants, as well as CAR T-cell therapy.

Jessica Rebeiro, MN, NP, CON(C)

Nurse Practitioner, Malignant Hematology
Juravinski Hospital
Hamilton, ON

Jessica Rebeiro has spent the entirety of her nursing career in malignant hematology over the past 14 years. She first began as an oncology nurse at Princess Margaret Cancer Centre. She completed the Master of Nursing Nurse Practitioner program at the University of Toronto. She went on to complete the first Ron and Nancy Clark Nurse Practitioner Fellowship in Hematology, and has now been a Nurse Practitioner within the Malignant Hematology program at Juravinski Hospital for almost 6 years. She has experience within the inpatient and outpatient acute leukemia, allogeneic and autologous stem cell transplant, and cellular therapy programs.

Christina Zeglinski MN, RN(EC), AGNP

Acute Care Nurse Practitioner
Medical Oncology and Malignant Hematology
Adjunct Lecturer, Lawrence Bloomberg Faculty of Nursing,
University of Toronto
Practice Based Researcher, Li Ka Shing Knowledge Institute,
Unity Health
Toronto, ON

Christina Zeglinski is a Nurse Practitioner (NP) with 15 years of hematology oncology experience. The bulk of her career has been in the Autologous Stem Cell Transplant (ASCT) and Immune Effector Cell (IEC) Program at Princess Margaret Cancer Centre (PM). During that time she co-developed both the outpatient ASCT and CAR T programs which are both NP-led programs. More recently, she transitioned to the community setting and currently works at St. Josephs Health Centre in both malignant hematology and medical oncology.

Christina actively holds an academic appointment as an Adjunct Lecturer at the Lawrence S. Bloomberg Faculty of Nursing at the University of Toronto as well as a Practice Based Researcher appointment at the Li Ka Shing Knowledge Institute at Unity Health. She is currently the primary investigator of a research study which aims to evaluate the effectiveness of a cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS) multimodal nursing educational program in a community hospital setting.

Matthew Ades, M.D., C.M., MHPE, FRCPC

Assistant Professor, McGill University
Division of General Internal Medicine, Jewish General Hospital
Montreal, QC

Dr. Matthew Ades obtained his MD from McGill University in 2018. He completed a three-year Internal Medicine residency at the Jewish General Hospital, followed by a two-year General Internal Medicine fellowship at McGill University, which he completed in June 2023. He subsequently completed a clinical fellowship in Vascular & Thrombosis Medicine at McMaster University in 2024.

Dr. Ades also holds a Master’s degree in Health Professions Education from the University of Ottawa. He currently serves as Director of the Cardiovascular Prevention Centre and Program Director of the AFC Thrombosis Training Program at McGill University. His clinical and academic focus is on atherothromboembolic and polyvascular disease, with an emphasis on interdisciplinary collaboration to develop integrated vascular medicine and arterial thrombosis care pathways.

Nicola Farnell, RN(EC), MN, CCHNC

Nurse Practitioner
Mount Sinai Fertility
Toronto, ON

Nicola Farnell is a Nurse Practitioner at Mount Sinai Fertility and an Adjunct Lecturer at Lawrence S. Bloomberg Faculty of Nursing. She is also a CIINDE-Certified Holistic Nurse Coach (CCHNC). She completed her Bachelor of Science in Nursing, Masters of Nursing and Acute Care Nurse Practitioner Program at University of Toronto. Her areas of clinical speciality include oncofertility, elective egg freezing and fertility care for gender diverse individuals”

Rachel LeBlanc, MN, NP-C, CON(C)

Specialty Nurse Practitioner
NS Cell Therapy & Transplant Program
Halifax, NS

Rachel has over a decade of nursing experience working with hematology, stem cell transplant, and cell therapy patients across the country, including Edmonton, Toronto, and Halifax. She obtained her Oncology Nursing Certification in 2017 and received her Master of Nursing (Nurse Practitioner) from U of T in 2021. She began her NP career at the Princess Margaret Cancer Center and returned home to Halifax in 2022, where she began working as the first NP in Atlantic Canada with CAR T-cell therapy patients, in addition to autologous and allogeneic transplant patients as part of the Nova Scotia Cell Therapy and Transplant Program (CTTP).